Burden of leishmaniasis in Brazil and federated units, 1990-2016: Findings from Global Burden of Disease Study 2016

被引:56
作者
Trindade Bezerra, Juliana Maria [1 ]
Miranda de Araujo, Valdelaine Etelvina [2 ]
Barbosa, David Soeiro [1 ]
Martins-Melo, Francisco Rogerlandio [3 ,4 ]
Werneck, Guilherme Loureiro [4 ]
Carneiro, Mariangela [1 ,5 ]
机构
[1] Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Epidemiol Infect & Parasit Dis Lab, Belo Horizonte, MG, Brazil
[2] Minist Hlth, Secretariat Hlth Surveillance, Brasilia, DF, Brazil
[3] Fed Inst Educ Sci & Technol Ceara, Caucaia, Ceara, Brazil
[4] Univ Fed Rio de Janeiro, Inst Publ Hlth Studies, Rio De Janeiro, RJ, Brazil
[5] Univ Fed Minas Gerais, Postgrad Program Hlth Sci Infectol & Trop Med, Belo Horizonte, MG, Brazil
来源
PLOS NEGLECTED TROPICAL DISEASES | 2018年 / 12卷 / 09期
基金
比尔及梅琳达.盖茨基金会;
关键词
VISCERAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; TEGUMENTARY LEISHMANIASIS; SYSTEMATIC ANALYSIS; STATE; EPIDEMIOLOGY; DISABILITY; INJURIES; REGIONS;
D O I
10.1371/journal.pntd.0006697
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background The study presents estimates for the burden of visceral leishmaniasis (VL) and cutaneous and mucocutaneous leishmaniasis (CML) in Brazil and its 27 federated units using data from the Global Burden of Disease Study (GBD) 2016. Methodology We report the incidence, years of life lost (YLL), years lived with disability (YLD), and disability-adjusted life years (DALY) for leishmaniasis in Brazil from 1990 to 2016. The metrics are presented as age-standardized rates per 100,000 inhabitants with their respective uncertainty intervals (95%UI) and relative percentages of change. Principal findings The age-standardized incidence rate of leishmaniasis decreased 48.5% from 1990 (71.0, 95%U124.3-150.7) to 2016 (36.5, 95%U124.7-50.9), whereas the age-standardized DALY increased 83.6% over the studied period from 12.2 (95%U17.9-18.8) to 22.4 (95%U113.336.2). The age-standardized incidence rate and YLL for VL increased by 52.9% and 108% from 1990 to 2016, respectively. Considering CML, the age-standardized incidence rate and YLD decreased by 51% and 31.8% respectively for the same period. For VL, similar profiles for male and female were observed, with YLL and DALY increasing over time; with males presenting slightly higher values. The highest YLL rates were among "under 1-year old" children, which increased 131.2% from 1990 to 2016. Regarding CML, the highest values of YLD and DALY were verified among males, and YLD values showed a similar profile, with rates increasing with age. The VL burden increased in some states in the Northeast and Southeast regions and decreased for CML in some Northern states. Conclusion The increase of VL burden over the study period might be associated with the difficulties in controlling the disease spread. Information regarding the weight of VL and CML, including the death and disability tolls that they cause, highlights the impact of these neglected diseases on public health and the importance of effective prevention and treatment.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] The burden of injury in China, 1990-2017: findings from the Global Burden of Disease Study 2017
    Duan Leilei
    Ye Pengpeng
    Haagsma, Juanita A.
    Jin Ye
    Wang Yuan
    Er Yuliang
    Deng Xiao
    Gao Xin
    Ji Cuirong
    Wang Linhong
    Bannick, Marlena S.
    Mountjoy-Venning, W. Cliff
    Hawley, Caitlin N.
    Liu, Zichen
    Smith, Mari
    James, Spencer L.
    Vos, Theo
    Murray, Christopher J. L.
    LANCET PUBLIC HEALTH, 2019, 4 (09) : E449 - E461
  • [42] The global epidemiology and burden of psychostimulant dependence: Findings from the Global Burden of Disease Study 2010
    Degenhardt, Louisa
    Baxter, Amanda J.
    Lee, Yong Yi
    Hall, Wayne
    Sara, Grant E.
    Johns, Nicole
    Flaxman, Abraham
    Whiteford, Harvey A.
    Vos, Theo
    DRUG AND ALCOHOL DEPENDENCE, 2014, 137 : 36 - 47
  • [43] Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
    Xie, Yan
    Bowe, Benjamin
    Mokdad, Ali H.
    Xian, Hong
    Yan, Yan
    Li, Tingting
    Maddukuri, Geetha
    Tsai, Cheng-You
    Floyd, Tasheia
    Al-Aly, Ziyad
    KIDNEY INTERNATIONAL, 2018, 94 (03) : 567 - 581
  • [44] The global, regional, and national burden of leishmaniasis: An ecologic analysis from the Global Burden of Disease Study 1990-2017
    Scheufele, Christian J.
    Giesey, Rachel L.
    Delost, Gregory R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (04) : 1203 - 1205
  • [45] Burden and trends of mental disorders in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019
    Deng, Yang
    Sun, Siwei
    Wu, Shixing
    Chen, Kun
    Liu, Yan
    Wei, Wannian
    Bei, Ning
    Qiu, Chengjun
    Li, Xiaomei
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2024, 59 (09) : 1563 - 1576
  • [46] The global burden of gout: estimates from the Global Burden of Disease 2010 study
    Smith, Emma
    Hoy, Damian
    Cross, Marita
    Merriman, Tony R.
    Vos, Theo
    Buchbinder, Rachelle
    Woolf, Anthony
    March, Lyn
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (08) : 1470 - 1476
  • [47] Tobacco Smoking Status and the Contribution to Burden of Diseases in Iran, 1990-2010: Findings from the Global Burden of Disease Study 2010
    Ghasemian, Anoosheh
    Rezaei, Nazila
    Moghaddam, Sahar Saeedi
    Mansouri, Anita
    Parsaeian, Mahboubeh
    Delavari, Alireza
    Jamshidi, Hamid Reza
    Sharifi, Farshad
    Naderimagham, Shohreh
    ARCHIVES OF IRANIAN MEDICINE, 2015, 18 (08) : 493 - 501
  • [48] Disability-Adjusted Life Years (DALY) for Cancers in Iran, 1990 to 2016: Review of Findings from the Global Burden of Disease Study
    Nahvijou, Azin
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2021, 50 (10) : 2095 - 2104
  • [49] Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010
    Degenhardt, Louisa
    Whiteford, Harvey A.
    Ferrari, Alize J.
    Baxter, Amanda J.
    Charlson, Fiona J.
    Hall, Wayne D.
    Freedman, Greg
    Burstein, Roy
    Johns, Nicole
    Engell, Rebecca E.
    Flaxman, Abraham
    Murray, Christopher J. L.
    Vos, Theo
    LANCET, 2013, 382 (9904) : 1564 - 1574
  • [50] Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
    Whiteford, Harvey A.
    Degenhardt, Louisa
    Rehm, Juergen
    Baxter, Amanda J.
    Ferrari, Alize J.
    Erskine, Holly E.
    Charlson, Fiona J.
    Norman, Rosana E.
    Flaxman, Abraham D.
    Johns, Nicole
    Burstein, Roy
    Murray, Christopher J. L.
    Vos, Theo
    LANCET, 2013, 382 (9904) : 1575 - 1586